Log in
NYSE:ARA

American Renal Associates Stock Forecast, Price & News

$11.44
-0.01 (-0.09 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$11.41
Now: $11.44
$11.46
50-Day Range
$11.41
MA: $11.47
$11.79
52-Week Range
$5.57
Now: $11.44
$11.98
Volume351,487 shs
Average Volume114,589 shs
Market Capitalization$394.90 million
P/E RatioN/A
Dividend YieldN/A
Beta1.23
American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.
Read More
American Renal Associates logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.99 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone978-922-3080
Employees4,977

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$822.52 million
Cash Flow$1.69 per share
Book Value$2.07 per share

Profitability

Net Income$-13,790,000.00

Miscellaneous

Market Cap$394.90 million
Next Earnings Date3/15/2021 (Estimated)
OptionableOptionable
$11.44
-0.01 (-0.09 %)
(As of 11/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ARA News and Ratings via Email

Sign-up to receive the latest news and ratings for ARA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











American Renal Associates (NYSE:ARA) Frequently Asked Questions

How has American Renal Associates' stock been impacted by COVID-19?

American Renal Associates' stock was trading at $7.14 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ARA shares have increased by 60.2% and is now trading at $11.44.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of American Renal Associates?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for American Renal Associates in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for American Renal Associates
.

What stocks does MarketBeat like better than American Renal Associates?

Wall Street analysts have given American Renal Associates a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but American Renal Associates wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is American Renal Associates' next earnings date?

American Renal Associates is scheduled to release its next quarterly earnings announcement on Monday, March 15th 2021.
View our earnings forecast for American Renal Associates
.

How were American Renal Associates' earnings last quarter?

American Renal Associates Holdings, Inc. (NYSE:ARA) released its earnings results on Wednesday, November, 11th. The company reported $0.15 earnings per share for the quarter, beating analysts' consensus estimates of $0.06 by $0.09. American Renal Associates had a negative return on equity of 3.56% and a negative net margin of 2.04%.
View American Renal Associates' earnings history
.

What price target have analysts set for ARA?

3 analysts have issued 12-month price targets for American Renal Associates' shares. Their forecasts range from $7.00 to $12.00. On average, they anticipate American Renal Associates' stock price to reach $8.67 in the next year. This suggests that the stock has a possible downside of 24.2%.
View analysts' price targets for American Renal Associates
.

Are investors shorting American Renal Associates?

American Renal Associates saw a decline in short interest in October. As of October 15th, there was short interest totaling 612,800 shares, a decline of 24.6% from the September 30th total of 813,100 shares. Based on an average daily volume of 132,300 shares, the short-interest ratio is currently 4.6 days. Currently, 1.9% of the shares of the stock are short sold.
View American Renal Associates' Short Interest
.

Who are some of American Renal Associates' key competitors?

What other stocks do shareholders of American Renal Associates own?

Based on aggregate information from My MarketBeat watchlists, some companies that other American Renal Associates investors own include KemPharm (KMPH), Exelixis (EXEL), Amicus Therapeutics (FOLD), Madrigal Pharmaceuticals (MDGL), Mylan (MYL), Spectrum Pharmaceuticals (SPPI), Akorn (AKRX), Fate Therapeutics (FATE), Karyopharm Therapeutics (KPTI) and Kura Oncology (KURA).

Who are American Renal Associates' key executives?

American Renal Associates' management team includes the following people:
  • Mr. Joseph A. Carlucci, Co-Founder, CEO & Chairman (Age 66, Pay $1.06M)
  • Mr. Syed T. Kamal, Co-Founder, Pres & Director (Age 67, Pay $947.14k)
  • Dr. Don E. Williamson, Exec. VP & COO (Age 58, Pay $1.22M)
  • Mr. Mark C. Herbers, Interim CFO & Interim Chief Accounting Officer (Age 65)
  • Mr. Richard Pacheco CFE, AVA, MBA, VP of Admin.
  • Mr. Neal Minahan, Chief Compliance Officer & VP
  • Ms. Victoria A. Labriola Esq., M.B.A., VP, Gen. Counsel & Sec.
  • Ms. Jennifer Hood, VP of HR
  • Dr. Richard Cronin M.D., Chief Medical Officer
  • Ms. Shari Cousins R.N., C.N.N., Sr. VP of Clinical & Regulatory Services

When did American Renal Associates IPO?

(ARA) raised $161 million in an IPO on Thursday, April 21st 2016. The company issued 7,500,000 shares at a price of $20.00-$23.00 per share. BofA Merrill Lynch, Barclays and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

What is American Renal Associates' stock symbol?

American Renal Associates trades on the New York Stock Exchange (NYSE) under the ticker symbol "ARA."

Who are American Renal Associates' major shareholders?

American Renal Associates' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (2.82%), JPMorgan Chase & Co. (1.01%), State Street Corp (0.85%), Globeflex Capital L P (0.32%), Acadian Asset Management LLC (0.14%) and Arrowstreet Capital Limited Partnership (0.09%).
View institutional ownership trends for American Renal Associates
.

Which institutional investors are selling American Renal Associates stock?

ARA stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, State Street Corp, JPMorgan Chase & Co., BlackRock Inc., Seizert Capital Partners LLC, and New York State Common Retirement Fund.
View insider buying and selling activity for American Renal Associates
.

Which institutional investors are buying American Renal Associates stock?

ARA stock was bought by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Arrowstreet Capital Limited Partnership, and Globeflex Capital L P.
View insider buying and selling activity for American Renal Associates
.

How do I buy shares of American Renal Associates?

Shares of ARA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is American Renal Associates' stock price today?

One share of ARA stock can currently be purchased for approximately $11.44.

How big of a company is American Renal Associates?

American Renal Associates has a market capitalization of $394.90 million and generates $822.52 million in revenue each year. The company earns $-13,790,000.00 in net income (profit) each year or $0.26 on an earnings per share basis. American Renal Associates employs 4,977 workers across the globe.

What is American Renal Associates' official website?

The official website for American Renal Associates is www.americanrenal.com.

How can I contact American Renal Associates?

American Renal Associates' mailing address is 500 CUMMINGS CENTER SUITE 6550, BEVERLY MA, 01915. The company can be reached via phone at 978-922-3080 or via email at [email protected]

This page was last updated on 11/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.